Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $120.00 (Jefferies)
- Lowest: $85.00 (Oppenheimer)
- Average: $103.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$103.00 (+42.5%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$103.00 (+42.5%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/23/2026 | Oppenheimer | Les Sulewski | New Coverage | Perform (N/A) |
85.00 (N/A) |
77.91 (72.29) |
-7.21% | Details |
| 9/9/2026 | Leerink | Daniel Clark | New Coverage | Outperform (N/A) |
104.00 (N/A) |
70.23 (72.29) |
2.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
